Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
consideration in cases of essentially equal qualification (§ 2 SGB IX). Contact and Application More information on the working group can be found here: https://www.leibniz-lsb.de/en/research/research-sections
-
The LIT - Leibniz Institute for Immunotherapy (foundation under civil law) (https://lit.eu/ ) - is a biomedical research center focusing on translational immunology in the fields of cancer
-
part of the application and selection process, please refer to the privacy policy on our homepage at https://www.senckenberg.de/en/imprint/ Please visit our website at www.senckenberg.de for further
-
increasing sustainable economic prosperity and social participation under constantly changing conditions. Want to know more about us and your career opportunities? Come and meet us at https://www.ifo.de/en
-
, 2026. Further information is available online at https://www.uni-potsdam.de/berufungen. According to the Civil Servants Act of the State of Brandenburg (“Landesbeamtengesetz”), an inquiry must be made
-
processes the personal data of its applicants in accordance with European and German legal regulations. Further information on data protection and the processing of personal data can be found at: https
-
regulations. Further information on data protection and the processing of personal data can be found at: https://www.isas.de/en/datenschutz . The closing date for applications is February 2, 2026. Please apply
-
, please contact: Dr. Hamed Sabzalipoor, h.sabzalipoor.leibniz-lsb(at)tum.de . More information on the working group can be found here: https://www.leibniz-lsb.de/en/research/research-sections/section-i
-
The LIT - Leibniz Institute for Immunotherapy (foundation under civil law) (https://lit.eu ) is a biomedical research center in the UNESCO-world heritage city of Regensburg. Our objective is to
-
button e-mail application below). https://jobs.zalf.de/jobposting/87eff4d83746c879e13de920a790b7de9799bed80 If you have any questions, please do not hesitate to contact us: Dr. Mathias Hoffmann